These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31211461)

  • 1. Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar Ataxia.
    Diallo A; Jacobi H; Cook A; Giunti P; Parkinson MH; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Castaldo A; Rakowicz M; Rola R; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Nachbauer W; Pandolfo M; Schulz JB; Bauer P; Jun-Suk K; Klockgether T; Tezenas du Montcel S
    Mov Disord; 2019 Aug; 34(8):1220-1227. PubMed ID: 31211461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
    Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
    Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dystonia and ataxia progression in spinocerebellar ataxias.
    Kuo PH; Gan SR; Wang J; Lo RY; Figueroa KP; Tomishon D; Pulst SM; Perlman S; Wilmot G; Gomez CM; Schmahmann JD; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Parkinsonism Relat Disord; 2017 Dec; 45():75-80. PubMed ID: 29089256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in dysphagia between spinocerebellar ataxia type 3 and type 6.
    Isono C; Hirano M; Sakamoto H; Ueno S; Kusunoki S; Nakamura Y
    Dysphagia; 2013 Sep; 28(3):413-8. PubMed ID: 23515636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominantly inherited ataxias: lessons learned from Machado-Joseph disease/spinocerebellar ataxia type 3.
    Paulson HL
    Semin Neurol; 2007 Apr; 27(2):133-42. PubMed ID: 17390258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurorehabilitation therapy in spinocerebellar ataxia type 2: A 24-week, rater-blinded, randomized, controlled trial.
    Rodríguez-Díaz JC; Velázquez-Pérez L; Rodríguez Labrada R; Aguilera Rodríguez R; Laffita Pérez D; Canales Ochoa N; Medrano Montero J; Estupiñán Rodríguez A; Osorio Borjas M; Góngora Marrero M; Reynaldo Cejas L; González Zaldivar Y; Almaguer Gotay D
    Mov Disord; 2018 Sep; 33(9):1481-1487. PubMed ID: 30132999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14.
    Chelban V; Wiethoff S; Fabian-Jessing BK; Haridy NA; Khan A; Efthymiou S; Becker EBE; O'Connor E; Hersheson J; Newland K; Hojland AT; Gregersen PA; Lindquist SG; Petersen MB; Nielsen JE; Nielsen M; Wood NW; Giunti P; Houlden H
    Mov Disord; 2018 Jul; 33(7):1119-1129. PubMed ID: 29603387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease.
    Matilla T; McCall A; Subramony SH; Zoghbi HY
    Ann Neurol; 1995 Jul; 38(1):68-72. PubMed ID: 7611728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar ataxias type 3 and 10: Onset and progression of ataxia during pregnancy and puerperium.
    Silva GV; Bonilha P; Moro A; Munhoz R; Raskin S; Ashizawa T; Nascimento FA; Teive HAG
    Parkinsonism Relat Disord; 2018 Jul; 52():119-120. PubMed ID: 29609848
    [No Abstract]   [Full Text] [Related]  

  • 11. Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2.
    Seemann J; Daghsen L; Cazier M; Lamy JC; Welter ML; Giese MA; Synofzik M; Durr A; Ilg W; Coarelli G
    Mov Disord; 2024 May; 39(5):788-797. PubMed ID: 38419144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
    Jacobi H; Bauer P; Giunti P; Labrum R; Sweeney MG; Charles P; Dürr A; Marelli C; Globas C; Linnemann C; Schöls L; Rakowicz M; Rola R; Zdzienicka E; Schmitz-Hübsch T; Fancellu R; Mariotti C; Tomasello C; Baliko L; Melegh B; Filla A; Rinaldi C; van de Warrenburg BP; Verstappen CC; Szymanski S; Berciano J; Infante J; Timmann D; Boesch S; Hering S; Depondt C; Pandolfo M; Kang JS; Ratzka S; Schulz J; Tezenas du Montcel S; Klockgether T
    Neurology; 2011 Sep; 77(11):1035-41. PubMed ID: 21832228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10.
    Moro A; Munhoz RP; Moscovich M; Arruda WO; Raskin S; Silveira-Moriyama L; Ashizawa T; Teive HAG
    Cerebellum; 2017 Dec; 16(5-6):938-944. PubMed ID: 28589261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials.
    Rodríguez-Labrada R; Velázquez-Pérez L; Auburger G; Ziemann U; Canales-Ochoa N; Medrano-Montero J; Vázquez-Mojena Y; González-Zaldivar Y
    Mov Disord; 2016 Apr; 31(4):570-8. PubMed ID: 26846400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARA captures disparate progression and responsiveness in spinocerebellar ataxias.
    Petit E; Schmitz-Hübsch T; Coarelli G; Jacobi H; Heinzmann A; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Pulst SM; Subramony SH; Ewenczyk C; Brice A; Durr A; Klockgether T; Ashizawa T; Tezenas du Montcel S
    J Neurol; 2024 Jul; 271(7):3743-3753. PubMed ID: 38822840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Dynamics of the Scale for the Assessment and Rating of Ataxia in Spinocerebellar Ataxias.
    Moulaire P; Poulet PE; Petit E; Klockgether T; Durr A; Ashisawa T; Tezenas du Montcel S;
    Mov Disord; 2023 Jan; 38(1):35-44. PubMed ID: 36273394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 5-Year Longitudinal Clinical and Magnetic Resonance Imaging Study in Spinocerebellar Ataxia Type 3.
    Piccinin CC; Rezende TJR; de Paiva JLR; Moysés PC; Martinez ARM; Cendes F; França MC
    Mov Disord; 2020 Sep; 35(9):1679-1684. PubMed ID: 32515873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in spinocerebellar ataxia type 12.
    Agarwal A; Kaur H; Agarwal A; Nehra A; Pandey S; Garg A; Faruq M; Rajan R; Shukla G; Goyal V; Srivastava AK
    Parkinsonism Relat Disord; 2021 Apr; 85():52-56. PubMed ID: 33740701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.